|
| 1 |
Indoxyl sulfate, homocysteine, and antioxidant capacities in patients at different stages of chronic kidney disease
Cheng-Hsu Chen, Shih-Chien Huang, En-Ling Yeh, Pei-Chih Lin, Shang-Feng Tsai, Yi-Chia Huang
Nutr Res Pract.2022;16(4):464-475. Published online 2021 December 2
DOI: http://dx.doi.org/10.4162/nrp.2022.16.4.464
|
|
| 2 |
Ursolic acid improves the indoxyl sulfate-induced impairment of mitochondrial biogenesis in C2C12 cells
Yutaro Sasaki, Akiko Kojima-Yuasa, Hinako Tadano, Ayaka Mizuno, Atsushi Kon, Toshio Norikura
|
|
| 3 |
Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study
You-Cheol Hwang, Se Won Kim, Kyu Yeon Hur, Bong-Soo Cha, In Joo Kim, Tae Sun Park, Sei Hyun Baik, Kun Ho Yoon, Kwan Woo Lee, In Kyu Lee, Moon-Kyu Lee
|
|
| 4 |
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment
Andrew HyoungJin Kim, Sumin Yoon, Yujin Lee, Jieon Lee, Eunjin Bae, Hajeong Lee, Dong Ki Kim, SeungHwan Lee, Kyung-sang Yu, In-Jin Jang, Joo-Youn Cho
|
|
| 5 |
Inhibition of indoxyl sulfate-induced intrarenal renin-angiotensin system activation: targeting the aryl hydrocarbon receptor
Muhammad Firman Akbar
|
|
| 6 |
AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving Hemodialysis
Jung-Hwa Ryu, Mina Yu, Sihna Lee, Dong-Ryeol Ryu, Seung-Jung Kim, Duk-Hee Kang, Kyu Bok Choi
|
|
